CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?
N Engl J Med
.
2022 Feb 17;386(7):692-696.
doi: 10.1056/NEJMe2118899.
Epub 2021 Dec 14.
Authors
Mark Roschewski
1
,
Dan L Longo
1
,
Wyndham H Wilson
1
Affiliation
1
From the Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD (M.R., W.H.W.).
PMID:
34904797
PMCID:
PMC9295142
DOI:
10.1056/NEJMe2118899
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Receptors, Chimeric Antigen*
Substances
Receptors, Chimeric Antigen
Grants and funding
Z99 CA999999/ImNIH/Intramural NIH HHS/United States